Turkish Validity and Reliability of the Behavioral Indicators of Pain Scale(ESCID)
Reliability and Validity of the Turkish Version of the Behavioral Indicators of Pain Scale in Mechanically Ventilated Intensive Care Unit Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
A significant proportion of patients hospitalized in intensive care units (ICUs) require mechanical ventilation, and the treatments applied during this process may cause pain. Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Although it is associated with delirium and agitation, pain is often an overlooked symptom in ICU patients, and a large proportion of mechanically ventilated patients continue to experience moderate to severe pain. The most common type of pain in critically ill patients is nociceptive pain, which may result from invasive procedures such as tracheal intubation, catheter insertion, aspiration, wound care, and patient repositioning. Additionally, the noisy and unfamiliar ICU environment and patients' inability to express themselves may further increase the perception of pain. Regular assessment of pain is associated with many positive outcomes, including more effective pain management, appropriate use of analgesic and sedative medications, and shorter duration of mechanical ventilation and ICU stay. Although self-reporting of pain is considered the gold standard, many patients receiving mechanical ventilation are unable to communicate their pain. Therefore, various behavioral pain assessment scales are used to evaluate pain in ICU patients. One of these tools is the Behavioral Indicators of Pain Scale (Escala de Conductas Indicadoras de Dolor - ESCID), which was developed to assess pain in critically ill adult patients receiving mechanical ventilation who are unable to communicate. However, a Turkish version of this scale has not yet been developed. Therefore, the aim of this study is to translate the ESCID scale into Turkish, perform its cultural adaptation, and test the validity and reliability of the Turkish version.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
ExpectedMarch 16, 2026
March 1, 2026
Same day
March 9, 2026
March 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Behavioral Indicators of Pain Scale (ESCID)
ESCID evaluates pain based on observable behavioral indicators, including facial expression, calmness, muscle tone, comfort level, and adaptation to mechanical ventilation. Each item is scored from 0 to 2, and the total score reflects the patient's level of pain. The application of ESCID allows systematic and objective pain assessment in patients who cannot self-report their pain.
5 month
Study Arms (1)
Single Group
OTHERThe ESCID scale will be applied to a sample of 50 patients.
Interventions
ESCID scale will be applied to 50 intubated ICU patients to assess pain through behavioral indicators. The study evaluate the Turkish validity and reliability of the ESCID scale.
Eligibility Criteria
You may qualify if:
- Individuals aged 18 years and older
- Patients who are intubated, receiving mechanical ventilation, and unable to establish verbal communication (Glasgow Coma Scale score \<14)
- Patients who have been hospitalized in the intensive care unit for at least 24 hours
You may not qualify if:
- Presence of postoperative complications
- Hemodynamic instability
- History of diagnosed cognitive or psychiatric disorders
- History of epilepsy or use of neuromuscular blocking agents
- History of spinal cord injury affecting motor function of all four extremities
- Individuals with a Richmond Agitation-Sedation Scale (RASS) score of -5 (unresponsive)
- Cases with suspected brain death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Saglik Bilimleri Universitesilead
- Fenerbahce Universitycollaborator
- Goztepe Prof Dr Suleyman Yalcın City Hospitalcollaborator
Study Sites (1)
Goztepe Prof Dr Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet Burak Uyaroğlu, Asst Prof
Fenerbahce University
- STUDY DIRECTOR
Esra Pehlivan, Prof Dr
Saglik Bilimleri University
- STUDY CHAIR
Hasan Kocoglu, Prof Dr
Medeniyet University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 12, 2026
Study Start
March 1, 2026
Primary Completion
March 1, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share